Related Experiment Video
Updated: Jul 9, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
A Consensus on Staphylococcus aureus Exacerbated Atopic Dermatitis and the Need for a Novel Treatment
Journal of Drugs in Dermatology : JDD
|October 3, 2024
Summary
Managing Staphylococcus aureus (S. aureus) in atopic dermatitis (AD) is challenging. Consensus statements offer guidance for healthcare providers on recognizing and treating S. aureus skin infections in AD, emphasizing antibiotic stewardship.
Area of Science:
- Dermatology
- Microbiology
- Pediatrics
Background:
- The skin microbiome is crucial for skin barrier function, inhibiting pathogen colonization.
- Decreased microbiome diversity is linked to increased Staphylococcus aureus (S. aureus) burden and atopic dermatitis (AD) severity.
- Managing S. aureus-driven AD is complex, with complications including exacerbations and secondary infections.
Purpose of the Study:
- To establish consensus statements on managing S. aureus-driven AD.
- To address challenges in treating AD with secondary bacterial infections.
- To identify unmet needs and new developments for improved patient care.
Main Methods:
- A modified Delphi process involving face-to-face discussions and blinded voting.
- A panel of 6 pediatric dermatologists developed consensus statements.
- Focus on S. aureus-driven AD exacerbation, treatment challenges, and patient outcomes.
Main Results:
- Five consensus statements were finalized by the expert panel.
- Recommendations are provided for healthcare providers treating secondary infected AD.
- The importance of recognizing and managing S. aureus skin infections in AD was underscored.
Conclusions:
- Consensus statements aim to improve clinical practice for S. aureus-driven AD.
- Promoting antibiotic stewardship is essential to mitigate antimicrobial resistance.
- A significant unmet need exists for a comprehensive topical AD therapy addressing multiple symptoms and severity levels.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...